Algorhythm shareholders approve 8x authorized share increase and reverse split up to 1:250

Algorhythm Holdings, Inc.

All six director nominees elected; quorum of 63.5% represented (9,029,136 shares).
Authorized common stock increased from 100M to 800M shares, approved by 8,568,396 votes.
Board authorized to implement reverse stock split between 1:10 and 1:250 within one year.
Amendment to 2022 Equity Incentive Plan approved; evergreen clause expanded.
Issuance of warrants and underlying shares from December 2024 offering ratified under Nasdaq rule 5635(d).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.